tiprankstipranks
Lytix Biopharma AS (DE:6BG)
FRANKFURT:6BG
Germany Market
Holding DE:6BG?
Track your performance easily

Lytix Biopharma AS (6BG) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Neutral
10Bullish
4Neutral
8Bearish
Technical Analysis Consensus
Buy
5Bullish
4Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Lytix Biopharma AS’s (6BG) Moving Averages Convergence Divergence (MACD) indicator is 0.01, suggesting Lytix Biopharma AS is a Buy.
Lytix Biopharma AS’s (6BG) 20-Day exponential moving average is 0.59, while Lytix Biopharma AS’s (6BG) share price is €0.588, making it a Buy.
Lytix Biopharma AS’s (6BG) 50-Day exponential moving average is 0.58, while Lytix Biopharma AS’s (6BG) share price is €0.588, making it a Buy.

Lytix Biopharma AS (6BG) Pivot Points

Dec 15, 2024, 05:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.60
0.60
0.60
0.60
0.60
0.60
0.60
Fibonacci
0.60
0.60
0.60
0.60
0.60
0.60
0.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Lytix Biopharma AS (6BG) Moving Averages

Dec 15, 2024, 05:35 AM
Period
Simple
Exponential
MA5
0.59Sell
0.60Sell
MA10
0.61Sell
0.60Sell
MA20
0.58Buy
0.59Buy
MA50
0.55Buy
0.58Buy
MA100
0.65Sell
0.60Sell
MA200
0.61Sell
0.59Buy
Lytix Biopharma AS’s (6BG) 10-Day exponential moving average is 0.60, while Lytix Biopharma AS’s (6BG) share price is €0.588, making it a Sell.
Lytix Biopharma AS’s (6BG) 100-Day exponential moving average is 0.60, while Lytix Biopharma AS’s (6BG) share price is €0.588, making it a Sell.
Lytix Biopharma AS’s (6BG) stock price is €0.588 and Lytix Biopharma AS’s (6BG) 50-day simple moving average is 0.55, creating a Buy signal.
Lytix Biopharma AS’s (6BG) stock price is €0.588 and Lytix Biopharma AS’s (6BG) 100-day simple moving average is 0.65, creating a Sell signal.
Lytix Biopharma AS’s (6BG) stock price is €0.588 and Lytix Biopharma AS’s (6BG) 200-day simple moving average is 0.61, creating a Sell signal.

Lytix Biopharma AS (6BG) Technical Indicators

Dec 15, 2024, 05:35 AM
Name
Value
Implied Action
RSI (14)
51.68
Neutral
STOCH (9,6)
11.32
Buy
STOCHRSI (14)
44.05
Neutral
MACD (12,26)
0.01
Buy
ADX (14)
12.38
Buy
Williams %R
-55.95
Buy
CCI (14)
16.15
Neutral
ATR (14)
0.02
-
Ultimate Oscillator
49.08
Neutral
ROC
7.27
Buy
Lytix Biopharma AS’s (6BG) Relative Strength Index (RSI) is 51.68, creating a Neutral signal.
Lytix Biopharma AS’s (6BG) Trend Strength Indicator (ADX) is 12.38, creating a Buy signal.
Lytix Biopharma AS’s (6BG) Commodity Channel Index (CCI) is 16.15, creating a Neutral signal.
Lytix Biopharma AS’s (6BG) Price Rate of Change (ROC) is 7.27, creating a Buy signal.

FAQ

Is 6BG a Buy, Hold, or Sell?
Based on 6BG’s technical indicators, 6BG is a Hold.
    What is 6BG’s RSI (14)?
    6BG’s RSI (14) is 51.68, which suggests 6BG is a Neutral.
      What is 6BG’s MACD?
      6BG’s MACD is 0.01, which suggests 6BG is a Buy.
        What is 6BG’s 5-day moving average?
        6BG’s 5-day moving average is 0.59, which suggests 6BG is a Sell.
          What is 6BG’s 20-day moving average?
          6BG 20-day moving average is 0.58, which suggests 6BG is a Buy.
            What is 6BG’s 50-day moving average?
            6BG’s 50-day moving average is 0.55, which suggests 6BG is a Buy.
              What is 6BG’s 200-day moving average?
              6BG’s 200-day moving average is 0.61, which suggests 6BG is a Sell.
                What is 6BG’s Williams % R (14)?
                6BG’s Williams % R (14) is -55.95, which suggests 6BG is a Buy.
                  What is 6BG’s CCI (14)?
                  6BG’s CCI (14) is 16.15, which suggests 6BG is a Neutral.
                    What is the share price of Lytix Biopharma AS?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis